#Generics remain under-used in #pharma market, despite potential for cost-savings. Read more here… https://t.co/S4weWSCGXH
Source by OECD
#Generics remain under-used in #pharma market, despite potential for cost-savings. Read more here… https://t.co/S4weWSCGXH
Source by OECD